Oruka Therapeutics Insider: Chief Medical Officer Buys 7,000 Shares While Selling Over 7,000 in 10b5‑1 Plan – A Dual‑Move Signaling Long‑Term Confidence in a Rising Pipeline
Oruka insider Joana’s buy‑sell pattern shows disciplined long‑term confidence, boosting investor optimism as analysts upgrade the stock and institutional buying rises.
3 minutes to read